Showing results (281-290 of 1,148) with videos related to
Sort By:
Pageof 115
Radiologic Clinics of North America|August 21, 2007
Nonprosthesis orthopedic applications of (18)F fluoro-2-deoxy-D-glucose PET in the detection of osteomyelitisJohannes Meller, Carsten Oliver Sahlmann, Torsten Liersch, et al.Frontiers in Bioscience (Elite Edition)|December 29, 2011
Functional oncoimaging techniques with potential clinical applicationsThomas C Kwee, Sandip Basu, Babak Saboury, et al.Expert Review of Respiratory Medicine|January 30, 2016
The role of PET/CT as a prognosticator and outcome predictor in lung cancerBenjapa Khiewvan, Pouya Ziai, Sina Houshmand, et al.Clinical Nuclear Medicine|April 22, 2022
Aducanumab-Related Amyloid-Related Imaging Abnormalities: Paean or Lament?Poul F Høilund-Carlsen, Thomas J Werner, Abass Alavi, et al.Clinical Nuclear Medicine|April 6, 2022
Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely NotAbass Alavi, Thomas J Werner, Poul Flemming Høilund-Carlsen, et al.Clinical Microbiology Reviews|January 19, 2008
Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomographyRakesh Kumar, Sandip Basu, Drew Torigian, et al.Annals of Nuclear Medicine|October 30, 2013
On the use of [18F]DOPA as an imaging biomarker for transplanted islet massOlof Eriksson, Akiva Mintz, Chengyang Liu, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2010
Prognostic implication of dual-phase PET in adenocarcinoma of the lungMohamed Houseni, Wichana Chamroonrat, Jiyuan Zhuang, et al.PET Clinics|June 21, 2016
Personalized Management Approaches in Lymphoma: Utility of Fluorodeoxyglucose-PET ImagingEmily C Ayers, Sara Fardin, Saeid Gholami, et al.PET Clinics|November 8, 2020
Assessment of Total-Body Atherosclerosis by PET/Computed TomographyPoul Flemming Høilund-Carlsen, Reza Piri, Oke Gerke, et al.Pageof 115